The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Analysis of the p53 pathway in clear cell renal cell carcinoma to identify novel drug combinations.
Mark T. Boyd
No relevant relationships to disclose
Amro Ahmed-Ebbiary
No relevant relationships to disclose
Radoslaw Polanski
No relevant relationships to disclose
Aidan Noon
No relevant relationships to disclose
Keith Parsons
No relevant relationships to disclose
Carlos P. Rubbi
No relevant relationships to disclose
Nikolina Vlatkovic
No relevant relationships to disclose